fda compounding semaglutide crackdown november 2025 is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified New project announcement: HHS‑OIG is
Pay in 4 interest-free payments of $6.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 24 - Nov 29



















:max_bytes(150000):strip_icc():focal(749x0:751x2)/Mans4-Gallbladder-Gets-Infected-from-GLP-1-042726-95779718fd494bd0a6af2a98bcafc118.jpg)




![Temple Garden (Retro Frame) [RVR - 414] Future Sight](https://cdn.shopify.com/s/files/1/0741/1970/8970/files/517643.jpg?v=1782402051)

